Physician profile
Efrain Rodriguez
NPI 1851852073
$2,191.63
in general payments reported to CMS, 2019-2025
16 companies · $648 in 2025
The $648 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $115 · 2023: $1,155 · 2024: $274 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $485.31 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $463.77 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Abbvie INC. | $400.49 | 2023-2024 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $258.58 | 2022-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $142.47 | 2023-2024 | |
| Corcept Therapeutics | $99.56 | 2025 | Korlym |
| Amgen INC. | $97.43 | 2023 | Repatha |
| Inspire Medical Systems, INC. | $45.24 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $42.41 | 2023 | Xarelto |
| Pfizer INC. | $37.19 | 2023-2024 | |
| Esperion Therapeutics, INC. | $24.93 | 2023 | Nexletol |
| Glaxosmithkline, LLC. | $24.10 | 2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Exact Sciences Corporation | $19.44 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $19.09 | 2023 | Veozah |
| Amarin Pharma, INC. | $16.89 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.73 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Efrain Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.